Zsolt Pál Harsányi is a businessperson who founded DynPort Vaccine Co. LLC and who has been at the head of 5 different companies. Presently, he holds the position of Chairman for Exponential Biotherapies, Inc. and Chairman of Emergent BioSolutions, Inc.
He is also on the board of Aptevo Therapeutics, Inc. and OptiFilter Research Zrt.
In the past Dr. Harsányi occupied the position of Chairman & Chief Executive Officer of Exponential Biotherapies, Inc., Chairman at N-Gene Research Laboratories, Inc., President at Porton International Plc and Vice President-Corporate Finance at E.F. Hutton & Co., Inc.
Dr. Harsányi received an undergraduate degree from Amherst College and a doctorate from Albert Einstein College of Medicine, Inc.